Delivery Order SPE2DB25D3006-SPE2DB25FXJPB
Award Date
6/20/25
Potential Completion Date
6/23/25
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GRALISE ER 600 MG TABLET 90S, a pharmaceutical product. The contract has a firm fixed price of $1,051.65 and a completion date of May 21, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,563.27, is for the supply of GRALISE ER 600 MG tablets. The contract has a period of performance through September 26, 2023 and is structured as a firm fixed-price delivery order. The contract was not set aside for any specific business type....
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of GRALISE ER 600 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $18,570.13 and a completion date of October 2, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at...
This is a federal delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency. The contract has a ceiling value of $16,364.93 and is for the delivery of the prescription medication Gralise ER 600 mg tablets. The contract is a Firm Fixed Price contract with a completion date of May 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the Defense Logistics...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,213.96 contract is for the supply of GRALISE ER 600 MG TABLET 90S, a prescription medication, with a completion date of November 16, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,441.79, is for the delivery of Gralise ER 300 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 6, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of GRALISE ER 600 MG TABLET 90S. The contract is a firm fixed price Delivery Order with a ceiling value of $1,787.25 and an ultimate completion date of June 23, 2025. This award is not a set-aside contract. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the drug GRALISE ER 300 MG TABLET 90S, with a ceiling value of $3,552.72 and a period of performance through June 17, 2025. The contract is priced on a firm-fixed-price basis and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gralise ER 300 mg tablets, a medication used for the treatment of neuropathic pain. The contract has a ceiling value of $37,507.84 and a completion date of December 13, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a...
This is a $8,879.52 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of GRALISE ER 600 MG TABLET 90S, a pharmaceutical product, with a performance period ending on May 13, 2025. Amerisourcebergen Drug Corp is a for-profit organization and a critical supplier of medical and pharmaceutical products to federal agencies, particularly the military healthcare...